View Older Stories View More Recent Stories
-
BMO Capital Starts AptarGroup (ATR) at Outperform
-
BMO Capital Starts Bemis (BMS) at Market Perform
-
BMO Capital Starts Rayonier (RYN) at Market Perform
-
BMO Capital Starts Crown Holdings (CCK) at Outperform
-
BMO Capital Starts Domtar (UFS) at Outperform
-
BMO Capital Starts Boise Cascade Company (BCC) at Outperform
-
BMO Capital Starts Louisiana-Pacific Corp (LPX) at Outperform
-
BMO Capital Starts Plum Creek Timber (PCL) at Outperform
-
BMO Capital Starts Weyerhaeuser (WY) at Outperform
-
Tetraphase Pharmaceuticals (TTPH) Higher on Trial Results; PT More than Doubled at BMO Capital
-
GrubHub (GRUB) Commences 10M Common Follow-On Offering
-
Streetinsider.com's Hot Lunchtime Reads 8/28: (TKMR) (MSFT) (ISIS) (WDAY)
-
ISIS Pharmaceuticals (ISIS) Bullish Stance Reiterated at BMO Capital Amid FCS Phase 3 Initiation
-
OncoMed Pharmaceuticals (OMED) Partial Clinical Hold Lift 'Significant', BMO Capital Says
-
Lending Club Files $500 Million IPO
-
TubeMogul (TUBE) PT Lifted at BMO Capital; Remains on Sidelines
-
ARIAD Pharma (ARIA) Gains on Strong Volume Amid Promising ICLUSIG Data
-
Notable Analyst Rating Changes 8/26: (MT) (ITMN) (MPEL) Upgraded; (QIHU) (SPG) (LIN) Downgraded
-
BMO Capital Downgrades Simon Property Group (SPG) to Market Perform
-
BMO Capital Upgrades The Macerich Company (MAC) to Outperform
-
Prescription Trends for ARIAD Pharma's (ARIA) ICLUSIG Reach Prior Levels - BMO Capital
-
Streetinsider.com's Hot Lunchtime Reads 8/25: (THI) (MSFT) (ADI) (RGDO)
-
Worst-Case Scenario Plays Out for Regado Biosciences (RGDO), BMO Capital Says
-
Notable Analyst Rating Changes 8/22: (SEAS) (AKS) (IBCP) Upgraded; (DE) (DCT) (AMPE) Downgraded
-
Brocade (BRCD) PT, Est. Raised at BMO Capital on Solid Q3, Conservative Guidance
-
BMO Capital Upgrades Edison International (EIX) to Outperform
-
BMO Capital Downgrades DCT Industrial Trust Inc. (DCT) to Market Perform
-
BMO Capital Downgrades Liberty Property Trust (LPT) to Market Perform
-
Hewlett-Packard (HPQ) Estimate Raised at BMO Capital Post Q3
-
BMO Capital Comments on Celgene (CELG) Following Publication of REVLIMID + R-CHOP Phase 2 Data
-
Health Care REIT (HCN) to Acquire HealthLease Properties REIT, Partner with Mainstreet
-
Notable Analyst Rating Changes 08/12: (ANF) (ICUI) (DF) Upgraded; (AMCC) (WHX) (TCK) Downgraded
-
Intercept Pharmaceuticals (ICPT) Bullish Stance Reiterated at BMO Capital Following FLINT Data
-
BMO Capital Starts TubeMogul, Inc (TUBE) at Market Perform
-
BMO Capital Downgrades Southwestern Energy (SWN) to Market Perform
-
BMO Capital Upgrades Carrizo Oil & Gas (CRZO) to Outperform
-
Notable Analyst Rating Changes 08/08: (ATVI) (ABX) (DK) Upgraded; (MYL) (HIBB) (SSYS) Downgraded
-
BMO Capital Upgrades Tornier (TRNX) to Outperform
-
BMO Capital Downgrades Hibbett Sports (HIBB) to Market Perform
-
Walt Disney (DIS) PT Raised to $96 at BMO Capital
-
Rocket Fuel (FUEL) to Acquire [x+1]; Deal Valued at $230M
-
Most Upgraded Stocks Over the Past Week (STRA) (TWTR) (WIN)
-
BMO Capital Downgrades Bally Technologies (BYI) to Market Perform
-
AGTC Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
BMO Capital Upgrades Build-A-Bear Workshop (BBW) to Outperform
-
BMO Capital Downgrades Helmerich & Payne (HP) to Market Perform
-
BMO Capital Upgrades Vantiv (VNTV) to Outperform
-
BMO Capital Upgrades Strayer Education (STRA) to Outperform
-
BMO Capital Downgrades Agnico-Eagle Mines Ltd. (AEM) to Market Perform
-
BMO Capital Upgrades BOK Financial (BOKF) to Market Perform

